These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 218109)

  • 1. The development of sustained action preparations of narcotic antagonists.
    Willette RE
    NIDA Res Monogr; 1978; (19):333-9. PubMed ID: 218109
    [No Abstract]   [Full Text] [Related]  

  • 2. A history of the development of narcotic antagonists for the treatment of narcotic addiction.
    Martin WR
    NIDA Res Monogr; 1978; (19):296-300. PubMed ID: 218106
    [No Abstract]   [Full Text] [Related]  

  • 3. Naltrexone in the treatment of opiate dependence.
    Resnick RB; Washton AM; Thomas MA; Kestenbaum RS
    NIDA Res Monogr; 1978; (19):321-32. PubMed ID: 218108
    [No Abstract]   [Full Text] [Related]  

  • 4. Update of naltrexone treatment.
    O'Brien CP; Greenstein R; Woody GE
    NIDA Res Monogr; 1978; (19):315-20. PubMed ID: 218107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of injectable microcapsules for use in the treatment of narcotic addiction.
    Thies C
    Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):19-20. PubMed ID: 1241971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narcotic antagonists: naltrexone pharmacochemistry and sustained-release preparations.
    NIDA Res Monogr; 1981; 28():1-273. PubMed ID: 6790998
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustained release of naltrexone from glyceride implants.
    Sullivan MF; Kalkwarf DR
    Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):27-32. PubMed ID: 967232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research and development of naltrexone: a new narcotic antagonist.
    Julius DA
    Am J Psychiatry; 1979 Jun; 136(6):782-6. PubMed ID: 220890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of depot naltrexone under legal coercion: the case for caution.
    Hall W; Capps B; Carter A
    Addiction; 2008 Dec; 103(12):1922-4. PubMed ID: 19469728
    [No Abstract]   [Full Text] [Related]  

  • 10. The development of sustained action preparations of narcotic antagonists.
    Willette RE
    NIDA Res Monogr; 1976 Sep; (9):31-4. PubMed ID: 1004531
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of polylactic/glycolic acid delivery systems for use in treatment of narcotic addiction.
    Schwope AD; Wise DL; Howes JF
    Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):13-8. PubMed ID: 1241970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones.
    Hahn EF; Nishimura S; Goodman RR; Pasternak GW
    J Pharmacol Exp Ther; 1985 Dec; 235(3):839-45. PubMed ID: 2416909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Narcotic withdrawal syndrome. Therapeutic methods].
    Cerdeño Impuesto V
    Rev Clin Esp; 1982 Oct; 167(1):65-9. PubMed ID: 6129686
    [No Abstract]   [Full Text] [Related]  

  • 14. Failure of naloxone and naltrexone to antagonize halothane anesthesia in the dog.
    Pace NL; Wong KC
    Anesth Analg; 1979; 58(1):36-9. PubMed ID: 219728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of naltrexone, a long-acting opiate antagonist.
    Crabtree BL
    Clin Pharm; 1984; 3(3):273-80. PubMed ID: 6329589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abstinence treatments for opiate addicts: therapeutic community or naltrexone?
    Arndt I; McLellan AT; O'Brien CP
    NIDA Res Monogr; 1984 Mar; 49():275-81. PubMed ID: 6434972
    [No Abstract]   [Full Text] [Related]  

  • 17. Quaternary naltrexone: evidence for the central mediation of discriminative stimulus effects of narcotic agonists and antagonists.
    Valentino RJ; Herling S; Woods JH; Medzihradsky F; Merz H
    J Pharmacol Exp Ther; 1981 Jun; 217(3):652-9. PubMed ID: 6262493
    [No Abstract]   [Full Text] [Related]  

  • 18. Naloxone and naltrexone: actions and interactions at an opiate drug receptor on frog skeletal muscle fibers.
    Frank GB; Marwaha J
    J Pharmacol Exp Ther; 1979 Jun; 209(3):382-8. PubMed ID: 220407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained release of naltrexone from glyceride implants.
    Sullivan MF; Kalkward DR
    Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):27-32. PubMed ID: 1234982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of narcotic antagonists in the rehabilitation of opiate addicts: a review of naltrexone.
    Schecter A
    Am J Drug Alcohol Abuse; 1980; 7(1):1-18. PubMed ID: 6254356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.